Overcoming Obstacles to Treatment Acceptance

2021 ◽  
Vol 66 (1) ◽  
pp. 13
Keyword(s):  
2017 ◽  
Vol 20 (9) ◽  
pp. A402
Author(s):  
S Wiederkehr ◽  
E de Bock ◽  
M Chekroun ◽  
B Arnould

1995 ◽  
Vol 13 (5) ◽  
pp. 1255-1264 ◽  
Author(s):  
S B Yellen ◽  
D F Cella

PURPOSE Little is known about the influence of social factors on treatment preferences and desire for aggressive cancer therapy. The present study assessed subjective and objective social indicators in patient preferences for treatment. METHODS Cancer patients (N = 296) with diverse diagnoses and stages read sets of hypothetical vignettes describing patients with early-stage and advanced disease. In the first set, patients made decisions about treatment acceptance given varying levels of either increasing cure or extending survival. In the second set, the point at which patients shifted preferences from mild to severe treatment to improve likelihood of 1-year survival (switch point) was the dependent measure. We assessed the impact of quality-of-life (QL) domains measured by the Functional Assessment of Cancer Therapy-General (FACT-G), having children, marital status, and living arrangements on treatment preferences and switch points. RESULTS The Social Well-Being (SWB) subscale of the FACT-G predicted both treatment acceptance (P = .007) and switch point (P = .043) in the advanced-disease vignettes, with lower SWB associated with less aggressive preferences. Children living at home was likewise associated with more aggressive intent both in treatment preferences (P = .003, advanced-disease vignette) and switch point (P < .001 and P = .001 for early- and advanced-disease vignettes, respectively). Living with others predicted more aggressive intent in the advanced-disease vignette (P = .03). Marital status did not predict either treatment acceptance or switch point. CONCLUSION Positive social well-being, as well as having children living at home, predicted patient willingness to accept aggressive treatment. Willingness to receive aggressive treatment may explain or mediate previously reported salutory effects of social support on cancer outcomes.


2010 ◽  
Vol 1208 (1) ◽  
pp. 104-113 ◽  
Author(s):  
Steven Lindley ◽  
Holly Cacciapaglia ◽  
Delilah Noronha ◽  
Eve Carlson ◽  
Alan Schatzberg

2012 ◽  
Vol 5 (4) ◽  
pp. 239-249
Author(s):  
Claire Marant ◽  
Juliette Longin ◽  
Rémi Gauchoux ◽  
Benoit Arnould ◽  
Céderic Spizak ◽  
...  

2018 ◽  
Vol 11 ◽  
pp. 117863611881131 ◽  
Author(s):  
Lauren A Lambert ◽  
Dolly Katz ◽  
Pei-Jean Feng ◽  
Baby M Djojonegoro ◽  
Elizabeth Fair ◽  
...  

Objective: The aim of this study is to assess whether choice of test for tuberculosis (TB) infection affects decisions to accept and complete treatment among contacts to TB cases. Methods: Retrospective study is conducted in which TB contacts, ⩾15 years old during 2005 and 2009, were tested for infection with either a tuberculin skin test (TST) or an interferon-gamma release assay test, the QuantiFERON-TB Gold In-Tube (QFT-GIT). Results: Of 658 persons with valid test results, 185 (28%) had positive results, including 128 of 406 (32%) who had TST and 57 of 252 (23%) who received QFT-GIT. Treatment acceptance was 43 of 57 (75%) among QFT-GIT-positive and 97 of 128 (76%) among TST-positive persons (risk ratio [RR] = 1.0, 95% confidence interval [CI], 0.83-1.2). Treatment completion was 56% among QFT-GIT-positive (32 of 57) and 59% (75 of 128) among TST-positive persons (RR = 0.96, 95% CI, 0.73-1.26). Discussion: Our study showed no difference in proportions of TB contacts ⩾15 years old with positive TST results who accepted or completed LTBI treatment compared with those with positive QFT-GIT results. Future studies should include high-risk persons with no known TB exposure, who constitute the main reservoir for TB cases in the United States.


SLEEP ◽  
2000 ◽  
Vol 23 (1) ◽  
pp. 17-24 ◽  
Author(s):  
Mark H. Sanders ◽  
Joseph P. Costantino ◽  
Patrick J. Strollo ◽  
Karen Studnicki ◽  
Charles W. Atwood

2014 ◽  
Vol 125 ◽  
pp. S235
Author(s):  
M.V. Santos ◽  
M.A. Romano-Silva

Sign in / Sign up

Export Citation Format

Share Document